dihydroxyphenylalanine has been researched along with oxidopamine in 52 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (21.15) | 18.7374 |
| 1990's | 17 (32.69) | 18.2507 |
| 2000's | 17 (32.69) | 29.6817 |
| 2010's | 6 (11.54) | 24.3611 |
| 2020's | 1 (1.92) | 2.80 |
| Authors | Studies |
|---|---|
| Abassi, Z; Armando, I; Goldstein, DS; Grossman, E; Hoffman, A; Kopin, IJ | 1 |
| Engberg, G; Nissbrandt, H; Pileblad, E | 1 |
| Breathnach, AS; De Luca, C; Nazzaro-Porro, M; Passi, S; Picardo, M; Zompetta, C | 1 |
| Bédard, PJ; Gaudin, DP; Rioux, L | 1 |
| Carp, JS; Ohno, Y; Warnick, JE | 1 |
| Cohen, G; Evans, JM | 1 |
| Greiner, HE; Haase, AF; Seyfried, CA | 1 |
| Enz, A; Hefti, F; Melamed, E | 1 |
| Hiyama, Y; Sekihara, S; Suda, H; Terasawa, K; Watanabe, H | 1 |
| Adam, M; Boyes, BE; Cumming, P; Grierson, J; Martin, WR; McGeer, EG; Ruth, T | 1 |
| Hiyama, T; Kikuchi, T; Suzuki, S; Tsutsui, M; Yamada, K; Yasuda, Y | 1 |
| Kostrzewa, RM | 2 |
| Smith, GC; Willis, GL | 1 |
| Baumeister, A; Breese, GR; Frye, GD; Mueller, RA; Napier, TC | 1 |
| Jaim-Etcheverry, G; Zieher, LM | 1 |
| Bédard, PJ; Côté, PY; Grégoire, L; Parent, A; Roy, E | 1 |
| Hirose, T; Kikuchi, T; Miwa, T; Morita, S; Oshiro, Y; Tottori, K; Uwahodo, Y | 1 |
| Bennett, JP; Richard, MG | 2 |
| Nappi, AJ; Vass, E | 1 |
| Chrapusta, SJ; Egan, MF; Karoum, F; Wyatt, RJ | 1 |
| Lin, JY; Mai, LM; Pan, JT | 1 |
| Goshima, Y; Misu, Y; Yue, JL | 1 |
| Cohen, G; Evans, J | 1 |
| Ehrenström, F; Söderpalm, A; Söderpalm, B | 1 |
| Memoli, S; Nappi, AJ; Prota, G; Vass, E | 1 |
| Eisenhofer, G; Gould, L; Hansson, S; Harta, G; Hoffman, BJ; Hunyady, B; Mezey, E | 1 |
| Eisenhofer, G; Goldstein, DS; Harvey-White, J; Hooper, DR; Huynh, TT; Kawamura, M; Kopin, IJ; Nomura, T; Schwartz, JP | 1 |
| Arias-Montaño, JA; Molina-Hernández, A; Nuñez, A | 1 |
| Fisone, G; Goiny, M; Goldstein, M; Haycock, J; Herrera-Marschitz, M; Hökfelt, T; Lindgren, N; Lindskog, M; Xu, ZQ | 1 |
| Eldrup, E; Richter, EA | 1 |
| Jenner, P; Rose, S; Treseder, SA | 1 |
| Baklaushev, VP; Chekhonin, VP; Dmitrieva, TB; Filatova, TS; Kogan, BM; Lebedev, SV; Man'kovskaya, IV; Savchenko, EA; Yusupova, IU | 1 |
| Bardo, MT; Brown, RW; Dwoskin, LP; Green, TA; Phillips, SB | 1 |
| Chen, CY; Chou, YH; Huang, WS; Liu, JC; Liu, RS; Ma, KH | 1 |
| Cao, F; Sun, S; Tong, ET | 1 |
| Bergman, J; Eskola, O; Forsback, S; Grönroos, T; Haapalinna, A; Haaparanta, M; Marjamäki, P; Niemi, R; Rinne, J; Solin, O | 1 |
| Benoit, JP; Jollivet, C; Menei, P; Montero-Menei, CN; Sapin, A; Venier-Julienne, MC | 1 |
| Abe, H; Hashiguchi, H; Ishida, Y; Kawai, K; Magata, Y; Mukai, T; Saji, H; Takeda, R; Yoshimoto, M | 1 |
| Abe, H; Hashiguchi, H; Ishida, Y; Kawai, K; Magata, Y; Mukai, T; Saji, H; Takeda, R | 1 |
| Bertrand, A; Boulet, S; Carcenac, C; Feuerstein, C; Lacombe, E; Poupard, A; Savasta, M | 1 |
| Liu, MC; Liu, MY; Sakakibara, Y; Suiko, M; Yasuda, S | 1 |
| Bezard, E; Bioulac, BH; Gold, SJ; Gurevich, E; Hoang, CV; Kim, KW; LaHoste, GJ; Li, Q; Nadjar, A; Neve, RL; Pioli, E; Porras, G; Potts, BW; Qin, C; Waugh, JL | 1 |
| Björklund, T; Breysse, N; Carlsson, T; Carta, M; Hall, H; Kirik, D; Mandel, RJ; Soneson, C | 1 |
| Kita, H; Kita, T | 1 |
| Dinelle, K; Farrer, MJ; Holden, JE; Kornelsen, R; Mah, C; McCormick, S; Sossi, V; Stoessl, AJ; Walker, MD | 1 |
| Aley-Medina, P; Anaya-Martínez, V; Avila-Costa, MR; Espinosa-Villanueva, J; García-Ruiz, R; Gutiérrez-Valdez, AL; Montiel-Flores, E; Reynoso-Erazo, L; Sánchez-Betancourt, J; Torres-Esquivel, C; Tron-Alvarez, R | 1 |
| Alcacer, C; Charbonnier-Beaupel, F; Corvol, JC; Girault, JA; Hervé, D | 1 |
| Bahri, MA; Becker, G; Garraux, G; Hustadt, F; Lemaire, C; Luxen, A; Michel, A; Plenevaux, A | 1 |
| Berta, B; Gálosi, R; Kállai, V; Kovács, A; Lénárd, L; Ollmann, T; Péczely, L; Petykó, Z; Tóth, A | 1 |
| Avendaño-Estrada, A; Ávila-Rodríguez, MA; Verdugo-Díaz, L | 1 |
3 review(s) available for dihydroxyphenylalanine and oxidopamine
| Article | Year |
|---|---|
Reorganization of noradrenergic neuronal systems following neonatal chemical and surgical injury.
Topics: Adrenergic Fibers; Animals; Benzylamines; Brain; Dihydroxyphenylalanine; Guanethidine; Hydroxydopamines; Mice; Neurotoxins; Norepinephrine; Oxidopamine; Rats | 1988 |
Amine accumulation in behavioural pathology.
Topics: Animals; Behavior, Animal; Brain; Catecholamines; Cats; Colchicine; Consummatory Behavior; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dopamine beta-Hydroxylase; Histocytochemistry; Hydroxydopamines; Hypothalamic Area, Lateral; Hypothalamus; Kainic Acid; Medial Forebrain Bundle; Neural Pathways; Oxidopamine; Peripheral Nerves; Rats; Receptors, Dopamine; Serotonin; Substantia Nigra | 1985 |
Evolution of neurotoxins: from research modalities to clinical realities.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenergic Agents; Animals; Benzylamines; Botulinum Toxins, Type A; Dihydroxyphenylalanine; Dihydroxytryptamines; Glutamic Acid; Humans; Models, Animal; Nerve Growth Factor; Neurosciences; Neurotoxins; Oxidopamine; Terminology as Topic | 2009 |
49 other study(ies) available for dihydroxyphenylalanine and oxidopamine
| Article | Year |
|---|---|
Sympathoadrenal contribution to plasma dopa (3,4-dihydroxyphenylalanine) in rats.
Topics: Adrenal Glands; Animals; Arteries; Dihydroxyphenylalanine; Dopamine; Femoral Artery; Kidney; Male; Muscles; Oxidopamine; Rats; Rats, Inbred Strains; Sympathectomy, Chemical; Sympathetic Nervous System | 1992 |
The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra.
Topics: 5-Hydroxytryptophan; alpha-Methyltyrosine; Animals; Cerebral Cortex; Corpus Striatum; Desipramine; Dihydroxyphenylalanine; Dopamine; Hydrazines; Limbic System; Locus Coeruleus; Male; Maprotiline; Methyltyrosines; Neurotransmitter Uptake Inhibitors; Norepinephrine; Normetanephrine; Oxidopamine; Pargyline; Piperazines; Prosencephalon; Rats; Rats, Inbred Strains; Serotonin; Substantia Nigra; Synaptic Transmission | 1991 |
The oxyradical-scavenging activity of azelaic acid in biological systems.
Topics: Catalase; Cell Survival; Cells, Cultured; Dicarboxylic Acids; Dihydroxyphenylalanine; Dopamine; Dopamine Antagonists; Fibroblasts; Free Radical Scavengers; Free Radicals; Humans; Mannitol; Oxidation-Reduction; Oxidopamine; Oxygen; Superoxide Dismutase; Tumor Cells, Cultured; Ultraviolet Rays | 1991 |
Fetal dopamine neuron transplants prevent behavioral supersensitivity induced by repeated administration of L-dopa in the rat.
Topics: Animals; Dihydroxyphenylalanine; Dopamine; Embryo, Mammalian; Female; Hydroxydopamines; Oxidopamine; Rats; Stereotyped Behavior; Substantia Nigra | 1990 |
Prevention of phencyclidine-induced depression of the segmental reflex by L-3,4-dihydroxyphenylalanine in the rat spinal cord in vitro.
Topics: Animals; Chlorpromazine; Dihydroxyphenylalanine; Electric Stimulation; Female; Haloperidol; Hydroxydopamines; In Vitro Techniques; Male; Oxidopamine; Phencyclidine; Phentolamine; Rats; Rats, Inbred Strains; Reflex; Spinal Cord | 1989 |
Studies on the formation of 6-hydroxydopamine in mouse brain after administration of 2,4,5-trihydroxyphenylalanine (6-hydroxyDOPA).
Topics: Animals; Brain; Carbidopa; Cerebral Cortex; Chromatography, High Pressure Liquid; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Frontal Lobe; Hydroxydopamines; Male; Mice; Norepinephrine; Oxidopamine; Pargyline; Reserpine; Synaptic Vesicles | 1989 |
Biochemical and functional studies on EMD 49,980: a potent, selectively presynaptic D-2 dopamine agonist with actions on serotonin systems.
Topics: 4-Butyrolactone; 5-Hydroxytryptophan; Acetylcholine; Animals; Brain Chemistry; Dihydroxyphenylalanine; Dopamine Agents; Hippocampus; Hydroxydopamines; Indoles; Male; Oxidopamine; Oxindoles; p-Chloroamphetamine; Pyridines; Rats; Rats, Inbred Strains; Reserpine; Serotonin; Synaptosomes | 1989 |
Partial lesions of the nigrostriatal pathway in the rat. Acceleration of transmitter synthesis and release of surviving dopaminergic neurones by drugs.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; gamma-Aminobutyric Acid; Haloperidol; Homovanillic Acid; Hydroxydopamines; Male; Morphine; Neurons; Neurotransmitter Agents; Oxidopamine; Rats; Rats, Inbred Strains; Substantia Nigra | 1985 |
Functional compensation by transplantation of cell suspensions of embryonic mesencephalon into the striatum of rats with 6-hydroxydopamine lesions.
Topics: Animals; Apomorphine; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Hydrazines; Hydroxydopamines; Mesencephalon; Oxidopamine; Rats; Rats, Inbred Strains; Spiperone | 1986 |
The metabolism of [18F]6-fluoro-L-3,4-dihydroxyphenylalanine in the hooded rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Caudate Nucleus; Dihydroxyphenylalanine; Hydroxydopamines; Male; Oxidopamine; Rats; Rats, Inbred Strains | 1987 |
7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist.
Topics: Animals; Apomorphine; Brain; Corpus Striatum; Diencephalon; Dihydroxyphenylalanine; Frontal Lobe; Hydroxydopamines; Kainic Acid; Kinetics; Male; Mice; Mice, Inbred ICR; Motor Activity; Oxidopamine; Piperazines; Piperidines; Quinolines; Quinolones; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Telencephalon | 1988 |
Evidence that D-1 dopamine receptors contribute to the supersensitive behavioral responses induced by L-dihydroxyphenylalanine in rats treated neonatally with 6-hydroxydopamine.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Analysis of Variance; Animals; Animals, Newborn; Behavior, Animal; Benzazepines; Dihydroxyphenylalanine; Drug Interactions; Ergolines; Female; Flupenthixol; Haloperidol; Hydroxydopamines; Levodopa; Male; Motor Activity; Oxidopamine; Pregnancy; Quinpirole; Rats; Receptors, Dopamine; Self Mutilation; Stereotyped Behavior | 1985 |
Neurotoxins and developing monoaminergic neurons.
Topics: Adrenergic Fibers; Amines; Animals; Animals, Newborn; Benzylamines; Blood-Brain Barrier; Dihydroxyphenylalanine; Hydroxydopamines; Nervous System; Oxidopamine; Rats | 1983 |
Mesencephalic grafts partially restore normal nigral dynorphin levels in 6-hydroxydopamine-lesioned rats treated chronically with L-dihydroxyphenylalanine.
Topics: Amphetamine; Animals; Apomorphine; Brain Tissue Transplantation; Dihydroxyphenylalanine; Dopamine Agents; Dopamine Agonists; Dynorphins; Female; Fetal Tissue Transplantation; Image Processing, Computer-Assisted; Levodopa; Oxidopamine; Rats; Rats, Sprague-Dawley; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase | 1995 |
7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity.
Topics: 4-Butyrolactone; Animals; Antipsychotic Agents; Apomorphine; Aripiprazole; Catalepsy; Corpus Striatum; Dihydroxyphenylalanine; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Drug Interactions; Male; Mice; Mice, Inbred ICR; Motor Activity; Oxidopamine; Piperazines; Presynaptic Terminals; Quinolones; Radioligand Assay; Rats; Reserpine; Spiperone; Stereotyped Behavior; Synapses; Tritium | 1995 |
NMDA receptor blockade increases in vivo striatal dopamine synthesis and release in rats and mice with incomplete, dopamine-depleting, nigrostriatal lesions.
Topics: Animals; Arginine; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Excitatory Amino Acids; Male; Mice; Microdialysis; Nitroarginine; Oxidopamine; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Substantia Nigra; Valine | 1995 |
The effects of glutathione and ascorbic acid on the oxidations of 6-hydroxydopa and 6-hydroxydopamine.
Topics: Antioxidants; Ascorbic Acid; Dihydroxyphenylalanine; Glutathione; Models, Chemical; Oxidation-Reduction; Oxidopamine | 1994 |
Regulation by D2 dopamine receptors of in vivo dopamine synthesis in striata of rats and mice with experimental parkinsonism.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Ergolines; Haloperidol; Hydrazines; Kinetics; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Oxidopamine; Parkinson Disease, Secondary; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Reference Values | 1994 |
Absence of 6-hydroxydopamine in the rat brain after treatment with stimulants and other dopaminergic agents: a mass fragmentographic study.
Topics: Animals; Brain; Carbidopa; Corpus Striatum; Dihydroxyphenylalanine; Dopamine Agents; Drug Combinations; Drug Stability; Frontal Lobe; Gas Chromatography-Mass Spectrometry; Injections, Intraventricular; Male; Oxidopamine; Pargyline; Rats; Rats, Sprague-Dawley; Stimulation, Chemical | 1993 |
Effects of systemic administration of 6-hydroxydopamine, 6-hydroxydopa and 1-methyl-4-phenyl-1,2,3,6-tetrahydroxypyridine (MPTP) on tuberoinfundibular dopaminergic neurons in the rat.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Arcuate Nucleus of Hypothalamus; Dihydroxyphenylalanine; Dopamine; Dose-Response Relationship, Drug; Neurons; Oxidopamine; Rats | 1993 |
Transmitter-like L-3,4-dihydroxyphenylalanine tonically functions to mediate vasodepressor control in the caudal ventrolateral medulla of rats.
Topics: Animals; Blood Pressure; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Dopamine; Electrochemistry; Hemodynamics; Levodopa; Male; Medulla Oblongata; Microdialysis; Microinjections; Norepinephrine; Oxidopamine; Rats; Rats, Wistar; Stereotaxic Techniques | 1993 |
Catecholamine uptake inhibitors elevate 6-hydroxydopamine in brain after administration of 6-hydroxydopa.
Topics: Animals; Axons; Brain; Catecholamines; Cerebral Cortex; Chromatography, High Pressure Liquid; Desipramine; Dihydroxyphenylalanine; Membranes; Mice; Nerve Endings; Neurons; Nomifensine; Oxidopamine | 1993 |
The yohimbine-induced anticonflict effect in the rat, Part II. Neurochemical findings.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Animals; Behavior, Animal; Cerebral Cortex; Chlorides; Conflict, Psychological; Dihydroxyphenylalanine; Enzyme Inhibitors; gamma-Aminobutyric Acid; Hippocampus; Hydrazines; Hydroxyindoleacetic Acid; Male; Norepinephrine; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Reserpine; Serotonin; Yohimbine | 1995 |
The effects of hydroxyl radical attack on dopa, dopamine, 6-hydroxydopa, and 6-hydroxydopamine.
Topics: Benzoquinones; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Dopamine; Hydroxyl Radical; Melanins; Models, Chemical; Oxidation-Reduction; Oxidopamine; Quinones | 1995 |
A novel nonneuronal catecholaminergic system: exocrine pancreas synthesizes and releases dopamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antibodies; Base Sequence; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; DNA Primers; Dopamine; Immunohistochemistry; In Situ Hybridization; Male; Membrane Glycoproteins; Membrane Transport Proteins; Molecular Sequence Data; Neuropeptides; Oxidopamine; Pancreas; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; RNA Probes; RNA, Messenger; Sympathectomy, Chemical; Transcription, Genetic; Tyrosine 3-Monooxygenase; Vesicular Biogenic Amine Transport Proteins | 1996 |
Differential effects of chemical sympathectomy on expression and activity of tyrosine hydroxylase and levels of catecholamines and DOPA in peripheral tissues of rats.
Topics: Animals; Chromaffin Cells; Dihydroxyphenylalanine; Dopamine; Gene Expression Regulation, Enzymologic; Male; Neurons; Norepinephrine; Organ Specificity; Oxidopamine; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sympathectomy, Chemical; Sympathetic Nervous System; Transcription, Genetic; Tyrosine 3-Monooxygenase | 1999 |
Histamine H3-receptor activation inhibits dopamine synthesis in rat striatum.
Topics: Animals; Dihydroxyphenylalanine; Dopamine; Histamine Agonists; In Vitro Techniques; Male; Methylhistamines; Neostriatum; Neurotransmitter Agents; Oxidopamine; Potassium; Radioligand Assay; Rats; Rats, Wistar; Receptors, Histamine H3; Substantia Nigra; Sympatholytics; Synaptosomes; Tyrosine 3-Monooxygenase | 2000 |
Regulation of tyrosine hydroxylase activity and phosphorylation at Ser(19) and Ser(40) via activation of glutamate NMDA receptors in rat striatum.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Antibody Specificity; Catalytic Domain; Caudate Nucleus; Colforsin; Dihydroxyphenylalanine; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Glutamic Acid; In Vitro Techniques; Male; N-Methylaspartate; Neurons; Okadaic Acid; Oxidopamine; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Serine; Sympatholytics; Tyrosine 3-Monooxygenase | 2000 |
DOPA, dopamine, and DOPAC concentrations in the rat gastrointestinal tract decrease during fasting.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenalectomy; Animals; Chromatography, High Pressure Liquid; Digestive System; Dihydroxyphenylalanine; Dopamine; Epinephrine; Fasting; Gastric Mucosa; Kidney; Male; Muscle, Skeletal; Myocardium; Norepinephrine; Organ Specificity; Oxidopamine; Rats; Rats, Wistar; Sympathectomy, Chemical | 2000 |
The central aromatic amino acid DOPA decarboxylase inhibitor, NSD-1015, does not inhibit L-DOPA-induced circling in unilateral 6-OHDA-lesioned-rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Behavior, Animal; Biogenic Monoamines; Brain; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dopamine Agents; Dopamine Antagonists; Drug Combinations; Enzyme Inhibitors; Haloperidol; Homovanillic Acid; Hydrazines; Levodopa; Male; Medial Forebrain Bundle; Oxidopamine; Rats; Rats, Wistar; Stereotyped Behavior; Tyrosine | 2001 |
Catecholamines and their metabolites in the brain and urine of rats with experimental Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Catecholamines; Dihydroxyphenylalanine; Dopamine; Epinephrine; Homovanillic Acid; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar | 2000 |
Locomotor stimulant effects of nornicotine: role of dopamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzazepines; Dihydroxyphenylalanine; Dopamine; Dopamine Antagonists; Drug Synergism; Male; Motor Activity; Nicotine; Nucleus Accumbens; Oxidopamine; Rats; Rats, Sprague-Dawley; Salicylamides; Stimulation, Chemical; Sympathectomy, Chemical; Sympatholytics | 2002 |
99mTc-TRODAT-1 SPECT in healthy and 6-OHDA lesioned parkinsonian monkeys: comparison with 18F-FDOPA PET.
Topics: Animals; Corpus Striatum; Dihydroxyphenylalanine; Macaca; Metabolic Clearance Rate; Models, Animal; Organotechnetium Compounds; Oxidopamine; Parkinsonian Disorders; Radiopharmaceuticals; Reference Values; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tropanes | 2003 |
Experimental study on inhibition of neuronal toxical effect of levodopa by ginkgo biloba extract on Parkinson disease in rats.
Topics: Animals; Apoptosis; Dihydroxyphenylalanine; Drug Interactions; Drugs, Chinese Herbal; Ginkgo biloba; Levodopa; Male; Neurons; Oxidopamine; Parkinson Disease; Random Allocation; Rats; Rats, Wistar; Substantia Nigra | 2003 |
Uptake of 6-[18F]fluoro-L-dopa and [18F]CFT reflect nigral neuronal loss in a rat model of Parkinson's disease.
Topics: Amphetamine; Animals; Apomorphine; Autoradiography; Behavior, Animal; Brain; Brain Mapping; Central Nervous System Stimulants; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine Agonists; Functional Laterality; Immunohistochemistry; Levodopa; Male; Oxidopamine; Parkinson Disease; Propionates; Radioligand Assay; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Substantia Nigra; Sympatholytics; Tyrosine 3-Monooxygenase | 2004 |
Striatal tyrosine hydroxylase immunoreactive neurons are induced by L-dihydroxyphenylalanine and nerve growth factor treatment in 6-hydroxydopamine lesioned rats.
Topics: Animals; Corpus Striatum; Dihydroxyphenylalanine; Female; Nerve Growth Factor; Neurons; Oxidopamine; Rats; Rats, Sprague-Dawley; Tyrosine 3-Monooxygenase | 2004 |
Alteration of striatal [11C]raclopride and 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine uptake precedes development of methamphetamine-induced rotation following unilateral 6-hydroxydopamine lesions of medial forebrain bundle in rats.
Topics: Animals; Biological Transport; Carbon Radioisotopes; Dihydroxyphenylalanine; Fluorine Radioisotopes; Functional Laterality; Methamphetamine; Motor Activity; Oxidopamine; Prosencephalon; Raclopride; Radionuclide Imaging; Rats; Rotation; Tissue Distribution | 2005 |
Changes in dopamine D2 receptors and 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine uptake in the brain of 6-hydroxydopamine-lesioned rats.
Topics: Animals; Benzazepines; Brain; Cerebellum; Cerebral Cortex; Dihydroxyphenylalanine; Dopamine Antagonists; Ligands; Male; Neostriatum; Oxidopamine; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Sympathectomy, Chemical; Sympatholytics; Tissue Distribution | 2004 |
High-frequency stimulation of the subthalamic nucleus prolongs the increase in striatal dopamine induced by acute l-3,4-dihydroxyphenylalanine in dopaminergic denervated rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Data Interpretation, Statistical; Denervation; Dihydroxyphenylalanine; Dopamine; Dopamine Agents; Electric Stimulation; Extracellular Space; Homovanillic Acid; Male; Microdialysis; Neostriatum; Oxidopamine; Rats; Rats, Sprague-Dawley; Subthalamic Nucleus; Synaptic Transmission | 2007 |
Hydroxylated serotonin and dopamine as substrates and inhibitors for human cytosolic SULT1A3.
Topics: 5,7-Dihydroxytryptamine; Arylsulfotransferase; Blotting, Western; Cell Line, Tumor; Chromatography, Thin Layer; Cytosol; Dihydroxyphenylalanine; Dopamine; Enzyme Inhibitors; Gene Silencing; Humans; Hydroxylation; Kinetics; Oxidopamine; RNA, Small Interfering; Serotonin; Sulfotransferases; Sulfur Radioisotopes | 2007 |
RGS9-2 negatively modulates L-3,4-dihydroxyphenylalanine-induced dyskinesia in experimental Parkinson's disease.
Topics: Analysis of Variance; Animals; Behavior, Animal; Corpus Striatum; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine Agents; Dyskinesias; Female; Gene Expression Regulation; Macaca fascicularis; Mice; Mice, Knockout; MPTP Poisoning; Oxidopamine; RGS Proteins; Stereotyped Behavior; Sympatholytics | 2007 |
Optimization of continuous in vivo DOPA production and studies on ectopic DA synthesis using rAAV5 vectors in Parkinsonian rats.
Topics: Animals; Biopterins; Corpus Striatum; Dependovirus; Dihydroxyphenylalanine; Dopamine; Female; Genetic Therapy; GTP Cyclohydrolase; Immunohistochemistry; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Sympatholytics; Tyrosine 3-Monooxygenase | 2009 |
Cortical stimulation evokes abnormal responses in the dopamine-depleted rat basal ganglia.
Topics: Action Potentials; Animals; Basal Ganglia; Cerebral Cortex; Dihydroxyphenylalanine; Male; Motor Activity; Neural Pathways; Neurons; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Subthalamic Nucleus | 2011 |
In-vivo measurement of LDOPA uptake, dopamine reserve and turnover in the rat brain using [18F]FDOPA PET.
Topics: Animals; Corpus Striatum; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Fluorine Radioisotopes; Male; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Tomography, Emission-Computed | 2013 |
The combination of oral L-DOPA/rimonabant for effective dyskinesia treatment and cytological preservation in a rat model of Parkinson's disease and L-DOPA-induced dyskinesia.
Topics: Administration, Oral; Animals; Cannabinoid Receptor Antagonists; Corpus Striatum; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine Agents; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Male; Nerve Degeneration; Neuropil; Oxidopamine; Parkinsonian Disorders; Piperidines; Pyrazoles; Rats; Rimonabant; Substantia Nigra; Tyrosine 3-Monooxygenase | 2013 |
Mitogen- and stress-activated protein kinase 1 is required for specific signaling responses in dopamine-denervated mouse striatum, but is not necessary for L-DOPA-induced dyskinesia.
Topics: Animals; Antiparkinson Agents; Corpus Striatum; Dihydroxyphenylalanine; Dopaminergic Neurons; Dyskinesia, Drug-Induced; Female; Male; Mice, Inbred C57BL; Mice, Knockout; Mutation; Oxidopamine; Ribosomal Protein S6 Kinases, 90-kDa; Signal Transduction | 2014 |
Comparative assessment of 6-[
Topics: Animals; Apomorphine; Aromatic-L-Amino-Acid Decarboxylases; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Fluorine Radioisotopes; Image Processing, Computer-Assisted; Male; Neostriatum; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Receptors, Presynaptic; Stereotyped Behavior; Tyrosine | 2017 |
Destruction of noradrenergic terminals increases dopamine concentration and reduces dopamine metabolism in the medial prefrontal cortex.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic alpha-2 Receptor Antagonists; Animals; Dihydroxyphenylalanine; Dopamine; Dopamine Uptake Inhibitors; Extracellular Space; Male; Neural Pathways; Neurons; Norepinephrine; Oxidopamine; Piperazines; Prefrontal Cortex; Rats, Wistar; Yohimbine | 2018 |
Comparative analysis of striatal [
Topics: Animals; Corpus Striatum; Dihydroxyphenylalanine; Male; Oxidopamine; Parkinson Disease; Positron-Emission Tomography; Rats; Rats, Wistar | 2022 |